Viewing Study NCT00117650

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:19 PM
Ignite Modification Date: 2026-01-29 @ 5:50 PM
Study NCT ID: NCT00117650
Status: COMPLETED
Last Update Posted: 2015-04-03
First Post: 2005-06-30
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Safety and Efficacy Study of Ad2/Hypoxia Inducible Factor (HIF)-1α/VP16 Gene Transfer in Patients With Intermittent Claudication
Sponsor: Genzyme, a Sanofi Company
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Intermittent Claudication View
None Peripheral Vascular Disease View
None Atherosclerosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None leg pain View
None gene transfer View
None angiogenesis View
None Phase 2 View
None Genzyme View
None peripheral arterial disease View